Clinical Scorecard: Antimicrobial Peptide-Enhanced Gelatin-Modified Hyaluronic Acid Hydrogels for the Management of Chronic Wounds
At a Glance
Category
Detail
Condition
Chronic wounds including diabetic foot ulcers (DFU)
Key Mechanisms
Impaired healing due to chronic hyperglycaemia causing dysregulated inflammation and angiogenesis; bacterial infection risk
Target Population
Patients with chronic wounds, specifically diabetic foot ulcers
Care Setting
Wound care and management settings, including clinical and research environments
Key Highlights
Development of hyaluronic acid-based hydrogels chemically modified with acrylate groups and crosslinked with PEG dithiol for stability
Incorporation of thiolated gelatin enhances cell adhesion and bioactivity supporting key wound repair cells
Inclusion of cysteine-terminated antimicrobial peptide PP4-3.1 provides localized bactericidal activity against Staphylococcus aureus
Guideline-Based Recommendations
Diagnosis
Identify chronic wounds such as diabetic foot ulcers with impaired healing and bacterial colonization
Management
Use multifunctional hydrogels combining structural support, enhanced bioactivity, and localized antimicrobial effects
Incorporate gelatin at optimal concentration (0.5%) to improve hydrogel stability and cell adhesion
Apply antimicrobial peptides to target prevalent bacteria like Staphylococcus aureus
Monitoring & Follow-up
Assess wound healing progression and infection control during hydrogel treatment
Evaluate cellular response including fibroblast and endothelial cell adhesion and spreading
Risks
Potential for bacterial infection persistence if antimicrobial activity is insufficient
Need for further pre-clinical evaluation to confirm long-term safety and efficacy
Patient & Prescribing Data
Individuals with chronic wounds, particularly diabetic foot ulcers prone to infection and impaired healing
Hydrogels functionalized with gelatin and antimicrobial peptides provide a promising approach to accelerate healing by enhancing cell adhesion and delivering localized antimicrobial activity
Clinical Best Practices
Select hydrogels with rapid gelation and elastic properties to maintain wound dressing integrity
Optimize gelatin concentration to balance stability and bioactivity for effective cell support
Incorporate antimicrobial peptides targeting common wound pathogens to reduce infection risk
Monitor wound healing and infection status regularly to adjust treatment as needed
Support further research and clinical trials to validate hydrogel efficacy in chronic wound management
